biotech
Bio-AnalystSupplement research
person
arrow_backExplore/Beetroot Extract

Beetroot Extract

Blood pressure and vascular health

Partial research summary

Human studies reported a change with no confirmed comparison group in Blood pressure; while Studies with an unspecified organism reported a change with no confirmed comparison group in Blood pressure.

single- and combination-ingredient studies · Scope not specified · Individual ingredient effects cannot be separated · Human studies · Includes patient groups · Population not specified · between-group comparison · within-group comparison · comparator not confirmed

Publications for this result: 5 (3 awaiting review included)

Other outcomes and study details

Distinct publications linked to this topic: 19

  • Study conditions differ; results are shown descriptively and are not pooled.
  • Combination, formula, or class studies do not isolate this ingredient or establish synergy.
  • Some publications have not cleared source or interpretation review.
  • Some papers could not be reviewed, so this summary covers only findings that could be confirmed.

What has been studied?

Distinct human comparison papers: 3

Some studies tested several ingredients together. Those results cannot show this ingredient’s separate effect or establish synergy.

  • Blood pressure

    Other human research, including observational studies and reviews
    • A change was reported, but the comparison could not be confirmed.
      Combination study
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Ingredient combination
      • Unspecified population
      • Outcome role not specified
      • Timepoint: unspecified
      • Study comparison: unspecified
    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      Patient group
      Measurement and study conditions
      • Meta-analysis
      • Meta-analysis
      • Unknown intervention
      • Patient group
      • Biomarker
      • Study subject not identified
      • Timepoint: Single-dose to short-term; durations varied
      • Study comparison: Pooled BP changes across included nitrate trials; abstract does not identify a single comparator
  • Diastolic BP

    • Comparison result:A better result than the comparison group was reported.
      General population · Single ingredient
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Single ingredient
      • General population
      • Biomarker
      • Between-group comparison
      • Timepoint: Acute supplementation 2.5–3.5 hours after ingestion.
      • Study comparison: Acute nitrate-rich beetroot juice versus nitrate-depleted placebo comparison for diastolic BP.
  • nocturnal systolic BP variability

    Research with unclear study subject or type
    • Results for this measurement were mixed; no consistent conclusion can be drawn.
      General population · Single ingredient
      Measurement and study conditions
      • Meta-analysis
      • Meta-analysis
      • Single ingredient
      • General population
      • Secondary outcome
      • Between-group comparison
      • Study subject not identified
      • Timepoint: 24-hour ambulatory blood pressure monitoring
      • Study comparison: Beetroot juice versus placebo across four trials, with age and nitrite subgroup analyses; overall an
  • SBP

    • Comparison result:A better result than the comparison group was reported.
      Patient group · Combination study · 12 weeks
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Ingredient combination
      • Patient group
      • Primary outcome
      • Between-group comparison
      • Timepoint: 12 weeks
      • Study comparison: nitrate-rich beetroot juice (400 mg nitrate) versus otherwise identical nitrate-depleted beetroot ju
Other measured outcomes (1)
  • systolic BP

    • Comparison result:A better result than the comparison group was reported.
      General population · 2.5 hours post-supplementation
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Unknown intervention
      • General population
      • Primary outcome
      • Between-group comparison
      • Timepoint: 2.5 hours post-supplementation
      • Study comparison: Nitrate-rich beetroot juice versus nitrate-depleted juice on systolic BP

This result is held for interpretation. That does not mean research found no effect.

Outcome groups needing additional review (4)
  • 24-h systolic BP · Distinct papers needing additional review: 1Evidence criteria check: 1
  • flow-mediated dilation · Distinct papers needing additional review: 1Evidence criteria check: 1
  • resting systolic blood pressure · Distinct papers needing additional review: 1Evidence criteria check: 1
  • Systolic blood pressure · Distinct papers needing additional review: 1Evidence criteria check: 1

One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.

Research topics to explore

Research topics to explore

Review findings reported in each research area.

Topics with more linked papers appear first.

  • Exercise performance

    Related papers 26 · human comparison papers 10

    View results
    • 1,000-m run · Improvement reported · Some studies used more than one ingredient
    • Endurance Shuttle Walk Time · Improvement reported · Some studies used more than one ingredient · Some studies included patients or people with a deficiency

    More outcome groups: 28

  • Blood pressure and vascular health

    Related papers 19 · human comparison papers 3

    View selected result
  • Cognition

    Related papers 2 · human comparison papers 1

    View results
    • Reaction time of response to the cognitive tasks · Improvement reported
    • cognitive function · Interpretation held
  • Bone, joint, and mobility

    Related papers 1 · human comparison papers 1

    View results
    • maximal knee extensor torque · Improvement reported · Some studies included patients or people with a deficiency
  • Fatigue and energy

    Related papers 1 · comparison findings need further review

    View results
  • Glucose and metabolic health

    Related papers 1 · comparison findings need further review

    View results
    • insulin · Finding details are limited
  • Stress and mood

    Related papers 1 · comparison findings need further review

    View results
    • markers of oxidative stress · Interpretation held
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: B

The 66.2 evidence score includes 12 independent human studies and 10 clinical studies in the representative benefit area. The B tier reflects evidence directness, repetition, and consistency together.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 80

Papers linked to this topic 19 · distinct papers 19 · papers with a confirmed human comparison 3 · papers needing additional review 13

Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • 24-h systolic BP: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • Blood pressure: Sources represented in this measurement group: 5 · Distinct papers with human comparisons for this outcome: 0
  • Diastolic BP: Sources represented in this measurement group: 2 · Distinct papers with human comparisons for this outcome: 1
  • flow-mediated dilation: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • nocturnal systolic BP variability: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • resting systolic blood pressure: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • SBP: Sources represented in this measurement group: 4 · Distinct papers with human comparisons for this outcome: 1
  • Systolic blood pressure: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • systolic BP: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1

Exercise performance

What the research found

1500-m TT

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Single ingredient · General population

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

1,000-m run

The study reported improvement in this measurement.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Endurance Shuttle Walk Time

The study reported improvement in this measurement.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

exercise time

The study reported improvement in this measurement.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Isokinetic knee flexion power

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Single ingredient · General population

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

maximal knee extensor speed (Vmax)

The study reported improvement in this measurement.

Controlled study in people · Unknown intervention · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

mean power

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Peak power output

The study reported improvement in this measurement.

Controlled study in people · Ingredient combination · Unspecified population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

peak walking time

The study reported improvement in this measurement.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

power (Pmax)

The study reported improvement in this measurement.

Controlled study in people · Unknown intervention · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

rowing time

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Total work done during the sprints of the IST

The study reported improvement in this measurement.

Controlled study in people · Unknown intervention · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Vo(2)

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

muscle strength gains

Results for this measurement were mixed; no consistent conclusion can be drawn.

Review · Unknown intervention · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

resistance exercise performance

A change was reported, but the comparison could not be confirmed.

Controlled study in people · Single ingredient · General population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Time-to-exhaustion

A change was reported, but the comparison could not be confirmed.

Controlled study in people · Ingredient combination · Unspecified population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

walk distance

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Unknown intervention · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

average repetition time

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

countermovement jump performance

The study needs further checking before its result can be interpreted.

Meta-analysis · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 2 measured outcomes

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

GXT trials

The study needs further checking before its result can be interpreted.

Meta-analysis · Unknown intervention · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

isometric strength recovery

The study needs further checking before its result can be interpreted.

Meta-analysis · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

modified Yo-Yo IR1 test

The study needs further checking before its result can be interpreted.

Controlled study in people · Unknown intervention · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

MPO

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

PPO

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

time to task failure

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · General population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

time-trial

The study needs further checking before its result can be interpreted.

Meta-analysis · Unknown intervention · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

TT performance

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

TTE

The study needs further checking before its result can be interpreted.

Meta-analysis · Unknown intervention · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Separable contribution · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

2 papers · 2 measured outcomes

2 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

V̇o2peak

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · General population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

work decrement

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Blood pressure and vascular health

What the research found

Diastolic BP

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

SBP

The study reported improvement in this measurement.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

systolic BP

The study reported improvement in this measurement.

Controlled study in people · Unknown intervention · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

nocturnal systolic BP variability

Results for this measurement were mixed; no consistent conclusion can be drawn.

Meta-analysis · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Blood pressure

A change was reported, but the comparison could not be confirmed.

Controlled study in people · Ingredient combination · Unspecified population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

blood pressure

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Unknown intervention · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

24-h systolic BP

The study needs further checking before its result can be interpreted.

Controlled study in people · Unknown intervention · Patient group

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

blood pressure

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · General population

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

blood pressure

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

blood pressure

The study needs further checking before its result can be interpreted.

Review · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

diastolic BP

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Patient group

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

flow-mediated dilation

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

resting systolic blood pressure

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

SBP

The study needs further checking before its result can be interpreted.

Animal study · indirect · Ingredient combination · Patient group

This finding comes from animal or cell research. It does not establish the same effect in people.

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

SBP

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

SBP

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Systolic blood pressure

The study needs further checking before its result can be interpreted.

Review · Ingredient combination · Unspecified population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Cognition

What the research found

Reaction time of response to the cognitive tasks

The study reported improvement in this measurement.

Controlled study in people · Unknown intervention · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

cognitive function

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Bone, joint, and mobility

What the research found

maximal knee extensor torque

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Fatigue and energy

What the research found

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Glucose and metabolic health

What the research found

insulin

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Single ingredient · General population

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Stress and mood

What the research found

markers of oxidative stress

The study needs further checking before its result can be interpreted.

Meta-analysis · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 2 measured outcomes

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

Caution findings
0
Findings from individual and combined use, plus reviewed cautions
Key precautions
No combination cautions are available to show in the current data. This does not guarantee safety.
Review 1 combination findings and 0 findings that outperformed an ingredient alone.
These findings were reported in studies. They do not predict an individual's experience.

Reported improvements with combinations

Combination findings are grouped by how the study compared them. This is not a recommendation to combine ingredients.

Combinations with reported improvement

The combination showed improvement, but each ingredient's contribution is unclear.

CaffeineIn a randomized crossover trial of 20 healthy males, the combination of caffeine and beetroot juice significantly improved 1,000-m running performance compared to placebo (p < 0.01).